Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$98.98 - $115.74 $6.29 Million - $7.35 Million
63,500 Added 18.19%
412,600 $47.7 Million
Q2 2023

Aug 11, 2023

BUY
$96.34 - $112.38 $33.6 Million - $39.2 Million
349,100 New
349,100 $35.9 Million
Q4 2022

Feb 09, 2023

BUY
$62.39 - $113.8 $11.8 Million - $21.5 Million
188,700 New
188,700 $21.5 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Bck Capital Management LP Portfolio

Follow Bck Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Bck Capital Management LP with notifications on news.